Literature DB >> 28448101

Actinic Keratosis, a Chronic, Progressive Disease: Understanding Clinical Gaps to Optimise Patient Management.

Rino Cerio1, Thomas Dirschka, Brigitte Dréno, Ignasi Figueras Nart, John T Lear, Giovanni Pellacani, Ketty Peris, Andrés Ruiz de Casas.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28448101     DOI： 10.2340/00015555-2692

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   4.437


× No keyword cloud information.
  6 in total

1.  Updates on Treatment Approaches for Cutaneous Field Cancerization.

Authors:  Alisen Huang; Julie K Nguyen; Evan Austin; Andrew Mamalis; Jared Jagdeo
Journal:  Curr Dermatol Rep       Date:  2019-07-19

2.  Long-term efficacy of interventions for actinic keratosis: protocol for a systematic review and network meta-analysis.

Authors:  Theresa Steeb; Markus V Heppt; Lars Becker; Christoph Kohl; Lars E French; Carola Berking
Journal:  Syst Rev       Date:  2019-10-11

3.  Treatment Motivations and Expectations in Patients with Actinic Keratosis: A German-Wide Multicenter, Cross-Sectional Trial.

Authors:  Theresa Steeb; Anja Wessely; Dagmar von Bubnoff; Thomas Dirschka; Konstantin Drexler; Conrad Falkenberg; Jessica C Hassel; Kinan Hayani; Svea Hüning; Katharina C Kähler; Sigrid Karrer; Christian Krammer; Ulrike Leiter; Diana Lill; Enklajd Marsela; Andreas Meiwes; Dorothée Nashan; Suzan Nasifoglu; Lutz Schmitz; Judith Sirokay; Alexander Thiem; Jochen Utikal; Alexander Zink; Carola Berking; Markus V Heppt
Journal:  J Clin Med       Date:  2020-05-12       Impact factor: 4.241

Review 4.  Immune Checkpoint Blockade in Advanced Cutaneous Squamous Cell Carcinoma: What Do We Currently Know in 2020?

Authors:  Anja Wessely; Theresa Steeb; Ulrike Leiter; Claus Garbe; Carola Berking; Markus Vincent Heppt
Journal:  Int J Mol Sci       Date:  2020-12-06       Impact factor: 5.923

5.  Spontaneous regression rates of actinic keratosis: a systematic review and pooled analysis of randomized controlled trials.

Authors:  Theresa Steeb; Anne Petzold; Annkathrin Hornung; Anja Wessely; Carola Berking; Markus V Heppt
Journal:  Sci Rep       Date:  2022-04-07       Impact factor: 4.379

6.  Method of Assessing Skin Cancerization and KeratosesTM (MASCK™): development and photographic validation in multiple anatomical sites of a novel assessment tool intended for clinical evaluation of patients with extensive skin field cancerization.

Authors:  Christopher Baker; Amelia James; Madeleine Supranowicz; Lynda Spelman; Stephen Shumack; Judith Cole; Warren Weightman; Robert Sinclair; Peter Foley
Journal:  Clin Exp Dermatol       Date:  2022-03-22       Impact factor: 4.481
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.